IDYA
Price
$33.68
Change
-$0.03 (-0.09%)
Updated
Nov 19, 01:43 PM (EDT)
Capitalization
2.95B
132 days until earnings call
Intraday BUY SELL Signals
NRIX
Price
$14.30
Change
+$1.62 (+12.78%)
Updated
Nov 19, 02:01 PM (EDT)
Capitalization
1.28B
91 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IDYA vs NRIX

Header iconIDYA vs NRIX Comparison
Open Charts IDYA vs NRIXBanner chart's image
IDEAYA Biosciences
Price$33.68
Change-$0.03 (-0.09%)
Volume$300
Capitalization2.95B
Nurix Therapeutics
Price$14.30
Change+$1.62 (+12.78%)
Volume$100
Capitalization1.28B
IDYA vs NRIX Comparison Chart in %
IDYA
Daily Signal:
Gain/Loss:
NRIX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IDYA vs. NRIX commentary
Nov 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Hold and NRIX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 19, 2025
Stock price -- (IDYA: $33.70 vs. NRIX: $12.66)
Brand notoriety: IDYA and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 62% vs. NRIX: 49%
Market capitalization -- IDYA: $2.95B vs. NRIX: $1.28B
IDYA [@Biotechnology] is valued at $2.95B. NRIX’s [@Biotechnology] market capitalization is $1.28B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 1 FA rating(s) are green whileNRIX’s FA Score has 1 green FA rating(s).

  • IDYA’s FA Score: 1 green, 4 red.
  • NRIX’s FA Score: 1 green, 4 red.
According to our system of comparison, IDYA is a better buy in the long-term than NRIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 4 TA indicator(s) are bullish while NRIX’s TA Score has 4 bullish TA indicator(s).

  • IDYA’s TA Score: 4 bullish, 4 bearish.
  • NRIX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, IDYA is a better buy in the short-term than NRIX.

Price Growth

IDYA (@Biotechnology) experienced а +5.28% price change this week, while NRIX (@Biotechnology) price change was -1.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.28%. For the same industry, the average monthly price growth was -5.78%, and the average quarterly price growth was +64.73%.

Reported Earning Dates

IDYA is expected to report earnings on Mar 31, 2026.

NRIX is expected to report earnings on Feb 18, 2026.

Industries' Descriptions

@Biotechnology (-2.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($2.95B) has a higher market cap than NRIX($1.28B). IDYA YTD gains are higher at: 31.128 vs. NRIX (-32.803). NRIX has higher annual earnings (EBITDA): -248.7M vs. IDYA (-380.2M). IDYA has more cash in the bank: 670M vs. NRIX (429M). IDYA has less debt than NRIX: IDYA (26.6M) vs NRIX (56.5M). NRIX has higher revenues than IDYA: NRIX (83.7M) vs IDYA (7M).
IDYANRIXIDYA / NRIX
Capitalization2.95B1.28B230%
EBITDA-380.2M-248.7M153%
Gain YTD31.128-32.803-95%
P/E RatioN/AN/A-
Revenue7M83.7M8%
Total Cash670M429M156%
Total Debt26.6M56.5M47%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
PROFIT vs RISK RATING
1..100
60
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IDYANRIX
RSI
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 7 days ago
76%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
IDYA
Daily Signal:
Gain/Loss:
NRIX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OANMX160.310.37
+0.23%
Oakmark Institutional
MITEX16.89N/A
N/A
Matthews Asia Innovators Institutional
GAHPX29.99N/A
N/A
Goldman Sachs Emerging Markets Eq P
FOBPX20.91-0.10
-0.48%
Tributary Balanced Instl Plus
OAIEX14.90-0.12
-0.80%
Optimum International A

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with NUVL. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+1.08%
NUVL - IDYA
59%
Loosely correlated
-3.48%
NRIX - IDYA
58%
Loosely correlated
-1.02%
XENE - IDYA
58%
Loosely correlated
N/A
OCUL - IDYA
57%
Loosely correlated
-1.09%
IMTX - IDYA
57%
Loosely correlated
+8.99%
More